Event info

Date:	06 Nov
Time:	9:00-11:30
Venue:	Medicon Valley Alliance, Copenhagen

Contact person

Jannie Rask de Vitt

Network & Event Assistant

jrv@mva.org

+45 2629 2989



Harnessing Innovation, Technology and AI’s role in clinical development productivity

Medicon Valley Alliance and Fortrea would like to welcome you to a Good Morning Meeting 6th of November 2024.

Join us for an insightful exploration of the evolving clinical research landscape as our expert speakers delve into how digital health, technology, and AI are enhancing clinical development productivity. Gain a deeper understanding of the positive impact this is having on trial outcomes, and ways in which this is also affecting important measures such as sustainability.

Date: Wednesday 6th of November 2024
Time: 9:00 – 11:30
Venue: Medicon Valley Alliance, Arne Jacobsens Allé 15, 2300 Copenhagen S, Denmark – Hub 2

Program

9:00	Networking, registration and light breakfast
9:30	Welcome and introduction to Medicon Valley Alliance David Munis Zepernick, Director, Member Engagement & Communication, Medicon Valley Alliance
9:35	Technology Advancement: Innovation to Impact Alaric Jackson, Chief Technology and Data Officer, Fortrea will discuss how we are now at the tipping point of impacting development at scale leveraging technology.
9:55	The Role of Digital Health in Sustainability and Global Health Equality Clare Campbell-Cooper, Global head, Digital Health and Innovation, Fortrea discusses how decentralised elements can be both a challenge and an opportunity and highlights how programme design is critical to success.
10:15	AI Goes Nuclear: Current AI models consume so much energy that Microsoft has begun funding nuclear power plants to feed them. Are there more energy-conscious models in AI? Will this trend continue? What are some future architecture on the horizons of AI Research? Brian Dolan, Vice President, Artificial Intelligence and Machine Learning, Fortrea will delve into the context of clinical research.
10:40	Panel discussion Cheerag Shirodaria, VP CV and Metabolic Diseases, Fortrea and Ken Park, VP Integrated Evidence Practice, Consulting, Fortrea lead an open discussion with our speakers and audience on key topics presented, company goals and ideas.
11:00	Networking
11:30	End of Good Morning Meeting

Speakers

	Alaric Jackson, Chief Technology and Data Officer, Fortrea Alaric Jackson is the Chief Technology & Data Officer at Fortrea. Alaric is rresponsible for developing and implementing Fortrea’s enterprise data and technology strategy allowing Fortrea to become the first CRO to be powered by AI. Prior to Fortrea, Alaric has held several Senior Leadership roles at Fern.Ai , GSK and IQVIA. Whilst at GSK he led the digital transformation of the Regulatory, Safety, Quality and Medical organisations.
	Clare Campell Cooper, Global head, Digital Health and Innovation, Fortrea Clare Campbell Cooper has 25 years of industry experience across all phases of clinical research, predominantly within CROs. Clare has a background in global project delivery and over 15 years of assisting clients develop strategies for successful study execution, with the last four being within digital health. She is a member of the Kings College Centre for Pharmaceutical Medicine Scientific Advisory Board, ACRO Regulatory Committees and TUFTs PACT Consortium amongst others. Clare regularly speaks at Innovation Symposiums and Conferences and has a special interest in removing boundaries and working in a precompetitive space.
	Brian Dolan, Vice President, Artificial Intelligence and Machine Learning, Fortrea Brian Dolan is a mathematician, inventor and cyberneticist with decades of experience building enterprise grade artificial intelligence products. Brian has 10 years of CXO experience leading multiple companies from seed to growth stage, including Yahoo, Greenplum and Deep6 AI and others. Brian is also a keynote speaker at major industry events such as TEDx, High Performance Computing and Big Data Day LA.
	Cheerag Shirodaria, VP CV and Metabolic Diseases, Fortrea Dr Cheerag Shirodaria is an interventional cardiologist with over 20 years of academic and clinical cardiology experience. He is Co-Director of a cardiac CT imaging program and a faculty member at University of Oxford. Dr Shirodaria is also Co-Founder and CDO of Caristo Diagnostics, an AI imaging company and has spent the past 13 years with Fortrea leading our cardiovascular and metabolic medical group.
	Ken Park, VP Integrated Evidence Practice, Consulting, Fortrea Dr Ken Park, MD has spent the last 20 years in healthcare, focused on building and delivering innovative businesses and solutions to the life sciences industry. He leads the Integrated Evidence Practice, working with clients to design and deliver comprehensive evidence plans incorporating clinical trials, RWE, and hybrid methods from early-phase clinical development through post-approval. As an Associate Principal at McKinsey & Co., he pioneered the establishment of Real-World Evidence in the Life Sciences industry and co-led the firm’s application of big data in healthcare. For six years, Dr. Park built new business lines across data, R&D services, and genomics as VP of Offering Development at IQVIA and most recently, he was co-founder and CEO of Veda Life Sciences, a next-generation integrated research organization. Dr. Park has an AB cum laude in psychology from Harvard College and an MD from the University of Southern California, Keck School of Medicine.